News
Eric Green, M.D., Ph.D., formerly the NHGRI director, has been awarded by Fierce Pharma as a Fierce 50 Innovation Honoree. The Fierce 50 is designed to honor the 50 most influential leaders and organizations shaping the future of biopharma, healthcare, and life sciences. The Fierce editorial team
The AUTM on the Air podcast has recently produced an episode featuring the NIH’s Dr. Mukul Ranjan discussing the origins of the Nagoya Protocol and its ongoing challenges, as well as the United States’ decision to not participate. The Nagoya Protocol is a supplement to the UN’s convention on
The Bayh-Dole Coalition has made all of the key documents in the Bayh-Dole legislation public and virtually accessible through a new online library. Previously, these documents were inaccessible and not housed together. Now, these documents have been compiled and annotated with the intent of
NIH will host a free virtual workshop titled Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer. This workshop will discuss the policies and practices that shape biomedical innovation and promote access to NIH-funded discoveries. It will also cover how